• レポートコード:MRC2202A017 • 出版社/出版日:Persistence Market Research / 2021年12月9日 • レポート形態:英文、PDF、112ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Site Licence | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Enterprisewide | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、北米の動物用調剤薬品市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症の危機分析、主要成功要因、製品別分析、処方別分析、動物種類別分析、国家別分析、競争分析、仮定、調査手法など、以下の構成でまとめております。 |
North America Vet Compounding Pharmacies Market – Scope of Report
The latest publication by Persistence Market Research on the North America vet compounding pharmacies market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for North America Vet Compounding Pharmacies market and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the North America vet compounding pharmacies market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the North America vet compounding pharmacies market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the North America vet compounding pharmacies market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the North America vet compounding pharmacies market offers information divided into four important segments – product, formulation, animal type, and country. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
CNS Agents
Anti-Infective Agents
Hormones and Substitutes
Anti-inflammatory Agents
Others
Formulation
Oral
Injectables
Others
Animal Type
Companion Animals
Dogs
Cats
Equine
Others
Livestock Animals
Country
U.S.
Canada
Key Questions Answered in Report
Which countries will continue to remain the most profitable markets for vet compounding pharmacies in North America over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in North America?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the North America vet compounding pharmacies industry avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the North America vet compounding pharmacies market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the North America vet compounding pharmacies market more accurate and reliable.
レポート目次1. Executive Summary
1.1. North America Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Method Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. North America GDP Growth Outlook
4.1.2. North America Healthcare Expenditure Outlook
4.1.3. Parent Market Outlook
4.2. Forecast Factors – Relevance & Impact
4.2.1. Availability of Alternative Dosage
4.2.2. Frequent Dispensing of CNS Drugs As Extemporaneous Medications
4.2.3. Intermittent Drug Shortages
4.2.4. Commercial Unavailability of FDA-Approved Drug Products
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.3.4. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. COVID19 and Impact Analysis
5.3.1. Revenue by Product
5.3.2. Revenue by Formulation
5.3.3. Revenue by Animal Type
5.3.4. Revenue By Country
5.4. 2020 Market Scenario
5.5. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Key Success Factors
6.1. Treatment Adoption Analysis
6.2. Animal Healthcare Spending
6.3. Regulatory Scenario
6.4. 503A and 503B Pharmacy Comparative Analysis
7. North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (In US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (In US$ Mn) Trend By Product, 2016-2020
8.3. Current and Future Market Size (In US$ Mn) Trend Analysis and Forecast By Product, 2021-2031
8.3.1. CNS Agents
8.3.2. Anti-Infective Agents
8.3.3. Hormones and Substitutes
8.3.4. Anti-inflammatory Agents
8.3.5. Others
8.4. Market Attractiveness Analysis By Product
9. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, By Formulation
9.1. Introduction / Key Findings
9.2. Historical Market Size (In US$ Mn) Trend By Formulation, 2016-2020
9.3. Current and Future Market Size (In US$ Mn) Trend Analysis and Forecast By Formulation, 2021-2031
9.3.1. Oral
9.3.2. Injectable
9.3.3. Others
9.4. Market Attractiveness Analysis By Formulation
10. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, By Animal Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (In US$ Mn) Trend By Animal Type, 2016-2020
10.3. Current and Future Market Size (In US$ Mn) Trend Analysis and Forecast By Animal Type , 2021-2031
10.3.1. Companion Animals
10.3.1.1.1. Dogs
10.3.1.1.2. Cats
10.3.1.1.3. Equine
10.3.1.1.4. Others
10.3.2. Livestock Animals
10.4. Market Attractiveness Analysis By Animal Type
11. North America Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Country
11.1. Introduction
11.2. Historical Market Size (In US$ Mn) Analysis By Country, 2016 – 2020
11.3. Current Market Size (In US$ Mn) Analysis and Forecast By Country, 2021 – 2031
11.3.1. U.S.
11.3.2. Canada
11.4. Market Attractiveness Analysis By Country
12. U.S. Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Historical Market Size (In US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020
12.3. Current and Future Market Size (In US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2021-2031
12.3.1. By Product
12.3.2. By Formulation
12.3.3. By Animal Type
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Canada Vet Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Historical Market Size (In US$ Mn) Trend Analysis By Market Taxonomy, 2016 – 2020
13.3. Current and Future Market Size (In US$ Mn) Trend Analysis Forecast By Market Taxonomy, 2021-2031
13.3.1. By Product
13.3.2. By Formulation
13.3.3. By Animal Type
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Competition Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Competition Deep Dive
14.3.1. Hoye’s Pharmacy
14.3.1.1. Business O
14.3.1.2. Product Portfolio
14.3.1.3. Strategy Overview
14.3.1.3.1. Marketing Strategy
14.3.1.3.2. Product Strategy
14.3.1.3.3. Channel Strategy
14.3.2. Vertisis Custom Pharmacy
14.3.2.1. Business O
14.3.2.2. Product Portfolio
14.3.2.3. Strategy Overview
14.3.2.3.1. Marketing Strategy
14.3.2.3.2. Product Strategy
14.3.2.3.3. Channel Strategy
14.3.3. Smith Caldwell Drug Store
14.3.3.1. Business O
14.3.3.2. Product Portfolio
14.3.3.3. Strategy Overview
14.3.3.3.1. Marketing Strategy
14.3.3.3.2. Product Strategy
14.3.3.3.3. Channel Strategy
14.3.4. Sixth Avenue Medical Pharmacy
14.3.4.1. Business O
14.3.4.2. Product Portfolio
14.3.4.3. Strategy Overview
14.3.4.3.1. Marketing Strategy
14.3.4.3.2. Product Strategy
14.3.4.3.3. Channel Strategy
14.3.5. Dougherty’s Pharmacy
14.3.5.1. Business O
14.3.5.2. Product Portfolio
14.3.5.3. Strategy Overview
14.3.5.3.1. Marketing Strategy
14.3.5.3.2. Product Strategy
14.3.5.3.3. Channel Strategy
14.3.6. Triangle Compounding Pharmacy Inc.
14.3.6.1. Business O
14.3.6.2. Product Portfolio
14.3.6.3. Strategy Overview
14.3.6.3.1. Marketing Strategy
14.3.6.3.2. Product Strategy
14.3.6.3.3. Channel Strategy
14.3.7. Medisca Inc.
14.3.7.1. Business O
14.3.7.2. Product Portfolio
14.3.7.3. Strategy Overview
14.3.7.3.1. Marketing Strategy
14.3.7.3.2. Product Strategy
14.3.7.3.3. Channel Strategy
14.3.8. Wedgewood Pharmacy
14.3.8.1. Business O
14.3.8.2. Product Portfolio
14.3.8.3. Strategy Overview
14.3.8.3.1. Marketing Strategy
14.3.8.3.2. Product Strategy
14.3.8.3.3. Channel Strategy
14.3.9. Millers Pharmacy
14.3.9.1. Business O
14.3.9.2. Product Portfolio
14.3.9.3. Strategy Overview
14.3.9.3.1. Marketing Strategy
14.3.9.3.2. Product Strategy
14.3.9.3.3. Channel Strategy
14.3.10. Chiron Compounding Pharmacy
14.3.10.1. Business O
14.3.10.2. Product Portfolio
14.3.10.3. Strategy Overview
14.3.10.3.1. Marketing Strategy
14.3.10.3.2. Product Strategy
14.3.10.3.3. Channel Strategy
14.3.11. MEDS Canadian Compounding Pharmacy
14.3.11.1. Business O
14.3.11.2. Product Portfolio
14.3.11.3. Strategy Overview
14.3.11.3.1. Marketing Strategy
14.3.11.3.2. Product Strategy
14.3.11.3.3. Channel Strategy
14.3.12. Aurora Compounding
14.3.12.1. Business O
14.3.12.2. Product Portfolio
14.3.12.3. Strategy Overview
14.3.12.3.1. Marketing Strategy
14.3.12.3.2. Product Strategy
14.3.12.3.3. Channel Strategy
14.3.13. Pace Pharmacy
14.3.13.1. Business O
14.3.13.2. Product Portfolio
14.3.13.3. Strategy Overview
14.3.13.3.1. Marketing Strategy
14.3.13.3.2. Product Strategy
14.3.13.3.3. Channel Strategy
14.3.14. Victoria Compounding Pharmacy
14.3.14.1. Business O
14.3.14.2. Product Portfolio
14.3.14.3. Strategy Overview
14.3.14.3.1. Marketing Strategy
14.3.14.3.2. Product Strategy
14.3.14.3.3. Channel Strategy
14.3.15. Pratt’s Compounding Pharmacy
14.3.15.1. Business O
14.3.15.2. Product Portfolio
14.3.15.3. Strategy Overview
14.3.15.3.1. Marketing Strategy
14.3.15.3.2. Product Strategy
14.3.15.3.3. Channel Strategy
14.3.16. People’s Choice Pharmacy
14.3.16.1. Business O
14.3.16.2. Product Portfolio
14.3.16.3. Strategy Overview
14.3.16.3.1. Marketing Strategy
14.3.16.3.2. Product Strategy
14.3.16.3.3. Channel Strategy
15. Assumptions and Acronyms Used
16. Research Methodology
Table 01: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By ProductTable 02: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Animal Type
Table 03: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Formulation
Table 04: North America Vet Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 05: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021- 2031, By Product
Table 06: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021- 2031, By Animal Type
Table 07: U.S. Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021- 2031, By Formulation
Table 08: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021-2031, By Product
Table 09: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021-2031, By Animal Type
Table 10: Canada Vet Compounding Pharmacies Market Value (US$ Mn) Analysis for 2016-2020, Estimate for 2021 and Forecast for 2021-2031, By Formulation